Last reviewed · How we verify
NCT04178915
Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections
trial testing Bood leukocyte subsets in Sepsis in 100 participants. Enrolling by invitation.
31 December 2025
Quick facts
| Lead sponsor | The Republican Research and Practical Center for Epidemiology and Microbiology |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 July 2019 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Belarus |
Drugs / interventions tested
- Bood leukocyte subsets
- The cholesterol content of the cell membrane of T-cells and monocytes
Conditions studied
- Sepsis — all drugs for Sepsis →
- Infective Endocarditis — all drugs for Infective Endocarditis →
- Pneumonia, Bacterial — all drugs for Pneumonia, Bacterial →
Sponsor
The Republican Research and Practical Center for Epidemiology and Microbiology — full company profile →
Who can join
Adults 18 to 60, any sex, with Sepsis or Infective Endocarditis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Current study evaluates the relationship between cell immunity and lipid transport systems in patients with severe bacterial infections (on the model of pneumonia, infective endocarditis, sepsis) in order to develop new methods for predicting the course and outcome of severe bacterial infections.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04178915
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bood leukocyte subsets
Trials testing the same drug.
- NCT05908162 — Algorithm for Predicting the Unfavorable Course of Sepsis in Children · completed
- NCT04392297 — Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals · completed
Other recruiting trials for Sepsis
Currently open trials in the same condition.
- NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
- NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
- NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
- NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
Other The Republican Research and Practical Center for Epidemiology and Microbiology trials
Trials by the same sponsor.
- NCT05908162 — Algorithm for Predicting the Unfavorable Course of Sepsis in Children · completed
- NCT04392297 — Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals · completed
- NCT03114631 — Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer · Phase 1, PHASE2 · completed
- NCT03130374 — Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells · Phase 1, PHASE2 · completed
- NCT03161951 — Differential Diagnostics of Etiology of Acute Infections · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04178915 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Republican Research and Practical Center for Epidemiology and Microbiology
- Last refreshed: 11 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04178915.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing